Advances in Specific Immunotherapy for Prostate Cancer
- 26 November 2007
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 53 (4), 694-708
- https://doi.org/10.1016/j.eururo.2007.11.043
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cellsCancer Immunology, Immunotherapy, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancerUrologic Oncology: Seminars and Original Investigations, 2006
- Antibody-based therapeutics: Focus on prostate cancerCancer and Metastasis Reviews, 2005
- Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue‐specific vaccine candidateEuropean Journal of Immunology, 2004
- Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude miceThe Prostate, 2003
- Development of HLA‐A2402/Kb transgenic miceInternational Journal of Cancer, 2002
- Identification of tumour-associated t-cell epitopes for vaccine developmentNature Reviews Cancer, 2002
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Molecular cloning of human prostate specific antigen cDNAFEBS Letters, 1987